Chronic myeloid leukemia, commonly with BCR-ABL translocation, showed continuous expression of STAT3 and STAT5, leading to enhanced expression of BCL-XL, which is an anti-apoptotic BCL2 family protein (81, 105). This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.